AZBio Board of Directors
Vice-President and Chief Financial Officer
Mr. Mower joined Regenesis Biomedical in 2018, bringing 20+ years of executive financial leadership with a focus on commercializing innovative medical device technologies.
Brian has successfully helped multiple companies obtain regulatory clearances, grow revenue, improve profitability, and increase shareholder value. He was recognized as the 2018 Minneapolis-Saint Paul Business Journal CFO of the year. He previously was CFO for Medibio Limited, an Australian public company. During his time there, he helped relocate international headquarters to Minneapolis, attain dual trading capacity, and obtain key regulatory clearances. He spent 8 years at Torax Medical (acquired by Johnson & Johnson), an implantable medical device technology firm, leading finance and international sales operations. Through regulatory clearances and high growth sales, he helped Torax grow from a pre-clinical start-up stage into a firm with 200+ hospital customers in 8 countries, before leading the successful acquisition by Ethicon, a J&J company. Brian also held CFO roles at other companies, including: Iomed, Inc., a publicly traded drug delivery company acquired by ReAble Therapeutics; EMPI, a pain management company acquired by DJO Global; and of DJO Global, an orthopedic and rehabilitation medical device firm.
Mr. Mower began his career in the international accounting firm KPMG, is a Certified Public Accountant, and has memberships in the AICPA and UACPA organizations. He received both Bachelor of Science and Master of Accountancy degrees from Brigham Young University.